These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 12406838)
41. Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials. Qin JP; Huang HB; Zhou H; Zhu Y; Xu Y; Du B Sci Rep; 2021 Mar; 11(1):6969. PubMed ID: 33772055 [TBL] [Abstract][Full Text] [Related]
42. Lung and serum teicoplanin concentration after aerosol and intravenous administration in a rat model. Mercier E; Darrouzain F; Montharu J; Guillon A; Diot P; Paintaud G; Vecellio L J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):306-12. PubMed ID: 24320618 [TBL] [Abstract][Full Text] [Related]
43. Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli. Giamarellos-Bourboulis EJ; Baziaka F; Antonopoulou A; Koutoukas P; Kousoulas V; Sabracos L; Panagou C; Perrea D; Giamarellou H Int J Antimicrob Agents; 2005 Feb; 25(2):168-72. PubMed ID: 15664488 [TBL] [Abstract][Full Text] [Related]
44. Antibacterial efficacy of inhaled squalamine in a rat model of chronic Pseudomonas aeruginosa pneumonia. Hraiech S; Brégeon F; Brunel JM; Rolain JM; Lepidi H; Andrieu V; Raoult D; Papazian L; Roch A J Antimicrob Chemother; 2012 Oct; 67(10):2452-8. PubMed ID: 22744759 [TBL] [Abstract][Full Text] [Related]
45. Influence of diluent volume of colistimethate sodium on aerosol characteristics and pharmacokinetics in ventilator-associated pneumonia caused by MDR bacteria. Bihan K; Zahr N; Becquemin MH; Lu X; Bertholon JF; Vezinet C; Arbelot C; Monsel A; Rouby JJ; Langeron O; Lu Q J Antimicrob Chemother; 2018 Jun; 73(6):1639-1646. PubMed ID: 29506194 [TBL] [Abstract][Full Text] [Related]
46. Lack of lung tissue and systemic accumulation after consecutive daily aerosols of amikacin in ventilated piglets with healthy lungs. Ferrari F; Goldstein I; Nieszkowszka A; Elman M; Marquette CH; Rouby JJ; Anesthesiology; 2003 Apr; 98(4):1016-9. PubMed ID: 12657868 [No Abstract] [Full Text] [Related]
47. Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs. Martinez-Olondris P; Rigol M; Soy D; Guerrero L; Agusti C; Quera MA; Li Bassi G; Esperatti M; Luque N; Liapikou M; Filella X; Marco F; de la Bellacasa JP; Torres A Crit Care Med; 2012 Jan; 40(1):162-8. PubMed ID: 21926613 [TBL] [Abstract][Full Text] [Related]
48. Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients. Delattre IK; Musuamba FT; Nyberg J; Taccone FS; Laterre PF; Verbeeck RK; Jacobs F; Wallemacq PE Ther Drug Monit; 2010 Dec; 32(6):749-56. PubMed ID: 20962708 [TBL] [Abstract][Full Text] [Related]
49. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195 [TBL] [Abstract][Full Text] [Related]
50. Pulmonary Deposition and Elimination of Liposomal Amikacin for Inhalation and Effect on Macrophage Function after Administration in Rats. Malinin V; Neville M; Eagle G; Gupta R; Perkins WR Antimicrob Agents Chemother; 2016 Nov; 60(11):6540-6549. PubMed ID: 27550345 [TBL] [Abstract][Full Text] [Related]
51. Mechanical ventilation-induced air-space enlargement during experimental pneumonia in piglets. Goldstein I; Bughalo MT; Marquette CH; Lenaour G; Lu Q; Rouby JJ; Am J Respir Crit Care Med; 2001 Mar; 163(4):958-64. PubMed ID: 11282773 [TBL] [Abstract][Full Text] [Related]
52. Once- versus twice-daily administration of amikacin in pediatric patients with bronchopneumonia: plasma drug concentration and Bayesian pharmacokinetics estimation. el Desoky ES; Shoreit AH Ann Pharmacother; 1999 Jun; 33(6):749-50. PubMed ID: 10410192 [No Abstract] [Full Text] [Related]
54. Effects of glucocorticoids in ventilated piglets with severe pneumonia. Sibila O; Luna CM; Agustí C; Baquero S; Gando S; Patrón JR; Morato JG; Absi R; Bassi N; Torres A Eur Respir J; 2008 Oct; 32(4):1037-46. PubMed ID: 18508831 [TBL] [Abstract][Full Text] [Related]
55. Amikacin dosing in neonates: evaluation of a dosing chart based on population pharmacokinetic data. Petersen PO; Wells TG; Kearns GL Dev Pharmacol Ther; 1991; 16(4):203-11. PubMed ID: 1782838 [TBL] [Abstract][Full Text] [Related]
56. A simple tool for monitoring nebulized amikacin treatments based on a single urine assay. Faurisson F; Delatour F; Jelazko P J Aerosol Med; 2001; 14(1):73-81. PubMed ID: 11495488 [TBL] [Abstract][Full Text] [Related]
57. Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study. Westerman EM; Le Brun PP; Touw DJ; Frijlink HW; Heijerman HG J Cyst Fibros; 2004 Mar; 3(1):23-8. PubMed ID: 15463883 [TBL] [Abstract][Full Text] [Related]
58. Animal model methodology: immunocompetent or leucopenic rats, which is the best? Results from a model of experimental pneumonia due to derepressed cephalosporinase-producing Enterobacter cloacae. Jacolot A; Judel C; Chaumais MC; Louchahi K; Nicolas P; Marchand S; Petitjean O; Mimoz O Chemotherapy; 2012; 58(2):129-33. PubMed ID: 22572147 [TBL] [Abstract][Full Text] [Related]